Form 4: Daxor Corp CEO Michael Feldschuh Acquires 3,360 Shares
SEC Form 4 Filing
Daxor Corp's CEO, Michael Richard Feldschuh, purchased 3,360 shares of Daxor Common Stock at $7.68 per share on March 10, 2025, increasing his direct holdings to 210,852 shares.
Summary
- On March 10, 2025, Michael Richard Feldschuh, the CEO of Daxor Corp, acquired 3,360 shares of Daxor Common Stock.
- The purchase price was $7.68 per share.
- Following this transaction, Feldschuh directly owns 210,852 shares of Daxor Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction. The CEO buying shares could be seen as a positive signal, but without further context, it's difficult to assess the overall impact.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders.
Stakeholder Impact
- Shareholders may view the CEO's purchase of shares as a positive sign of confidence in the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 03/10/2025 | Date of transaction: Michael Feldschuh purchased 3,360 shares of Daxor Common Stock. |
| 03/11/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.